Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 2 2Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 174Myeloid 64Lymphoid 28Thoracic 7Gastrointestinal 5Classical hematology 5Breast 4Plasma cell 3Genitourinary 3Sarcoma 2Head & Neck 2Gynecologic 2Dermatologic 1CNS 1

Conditions

Microsatellite Stable Colorectal Carcinoma 1Carcinoma, Ovarian Epithelial 1

Interventions

Paclitaxel 233Carboplatin 217Bevacizumab 139Cisplatin 134pembrolizumab 89Gemcitabine 69olaparib 54Docetaxel 47Topotecan 44Radiotherapy 43liposomal doxorubicin 41Taxes 41niraparib 38Cyclophosphamide 36Doxorubicin 30Letrozole 28Drug Therapy 28Nivolumab 27Magnetic Resonance Spectroscopy 25Immunoglobulin G 25Disulfides 24Oxaliplatin 23durvalumab 22Albumin-Bound Paclitaxel 22apatinib 21Etoposide 21Brachytherapy 21lenvatinib 20Specimen Handling 20Filgrastim 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Azacitidine × Gynecologic × Clear all
NCT02900560 2022-06-10

Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer

Translational Research in Oncology

Phase 2 Terminated
34 enrolled 15 charts
Gynecologic

Carcinoma, Ovarian Epithelial

NCT02811497 2021-04-01

METADUR

University Health Network, Toronto

Phase 2 Completed
28 enrolled
BreastGastrointestinalGynecologic

Microsatellite Stable Colorectal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡